VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / Skeena Resources Limited (TSX:SKE)(NYSE:SKE) ("Skeena Gold and Silver", "Skeena" or the "Company") is pleased to report continued progress on the permitting timeline for its 100%-owned Eskay Creek Gold-Silver Project ("Eskay" or the "Project"). The …
Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q1 CY2025, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per share was 2.3% above analysts’ consensus estimates. Is now the time to buy Zimmer Biomet? Find …
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But as Peter Lynch said …
Shareholders in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. Consensus estimates suggest investors could expect greatly increased statutory revenues and earnings per share, with the analysts modelling a real …
This story was originally published on Banking Dive. To receive daily news and insights, subscribe to our free daily Banking Dive newsletter. Having added new bankers and lending verticals, Associated Bank is chasing growth in its commercial bank, even as economic uncertainty lingers. Green …
Dundee Precious Metals, Inc. TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announces with great sadness the passing of R. Peter Gillin, Chair of the Company’s Board of Directors since 2022 and a director for …
The Descartes Systems Group Inc WATERLOO, Ontario and ATLANTA, May 05, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its first quarter fiscal 2026 financial results after market …
BioNTech SE Continued oncology pipeline advancement with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator BNT327, a bispecific antibody targeting PD-L1 and VEGF-A1, and mRNA cancer immunotherapies Presented multiple clinical updates across oncology pipeline underlining BioNTech’s combination strategy in oncology with first …
Key Insights Institutions' substantial holdings in Green Plains implies that they have significant influence over the company's share price The top 13 shareholders own 52% of the company Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a …
Pet food company Freshpet (NASDAQ:FRPT) reported Q1 CY2025 results topping the market’s revenue expectations , with sales up 17.6% year on year to $263.2 million. On the other hand, the company’s full-year revenue guidance of $1.14 billion at the midpoint came in 3.2% below …